International Journal of Molecular Sciences · 2021 · 28 citations · 33 references
Life SciencesBiochemistryPharmacologyEnzymologyProtein BiochemistryStructural BiologyEnzyme InhibitionPeptide AnalysisProtein BindingProtein DesignProtein StructureCholesterol-lowering EffectsEnzyme ActivityHmg-coa Reductase InhibitorsHmg-coa Reductase RegulationPeptide Structure - Activity RelationshipsSynthetic Long PeptidesTherapeutic Peptides
In this study, in silico approaches are employed to investigate the binding mechanism of peptides derived from cowpea β-vignin and HMG-CoA reductase. With the obtained information, we designed synthetic peptides to evaluate their in vitro enzyme inhibitory activity. In vitro, the total protein extract and <3 kDa fraction, at 5000 µg, support this hypothesis (95% and 90% inhibition of HMG-CoA reductase, respectively). Ile-Ala-Phe, Gln-Gly-Phe, and Gln-Asp-Phe peptides were predicted to bind to the substrate binding site of HMGCR via HMG-CoAR. In silico, it was established that the mechanism of HMG-CoA reductase inhibition largely entailed mimicking the interactions of the decalin ring of simvastatin and via H-bonding; in vitro studies corroborated the predictions, whereby the HMG-CoA reductase activity was decreased by 69%, 77%, and 78%, respectively. Our results suggest that Ile-Ala-Phe, Gln-Gly-Phe, and Gln-Asp-Phe peptides derived from cowpea β-vignin have the potential to lower cholesterol synthesis through a statin-like regulation mechanism.
33
Mohammad H. Forouzanfar, Ashkan Afshin, Lily Alexander et al. · The Lancet · 2016 · 7.8K citations · Full text
Python: a programming language for software integration and development.
M F Sanner · PubMed · 1999 · 3.1K citations
Structural Mechanism for Statin Inhibition of HMG-CoA Reductase
Eva S. Istvan, J. Deisenhofer · Science · 2001 · 1.6K citations